relation to the number of individual 2014 biologic drugs in use/on formulary at TA342 in July 2015 indications any one time for use within Rheumatoid applicable locally and confirmed Red ( Arthritis? hospital only) Red prescribing -What restrictions (if any) does the classification. have in place in CCG’s formulary relation to the number of individual TA352 in September 2015 applicable biologic drugs in use/on formulary at locally and included. any one time for use within Psoriatic Arthritis? -What restrictions (if any) does the formulary have in place in CCG’s -Finally, could you provide a link/attach relation to the number of individual to your response the latest versions of biologic drugs in use/on formulary at your patient pathways for Crohn’s any one time for use within Disease and Psoriatic Arthritis? Rheumatoid Arthritis? Prescribed in line with NICE guidance and as per formulary. No additional restriction. -What restrictions (if any) does the formulary have in place in CCG’s relation to the number of individual biologic drugs in use/on formulary at any one time for use within Psoriatic Arthritis? Prescribed in line with NICE guidance and as per formulary. No additional restriction. -Finally, could you provide a link/attach to your response the latest versions of your patient pathways for Crohn’s Disease and Psoriatic Arthritis? Follow national NICE pathways. According to your current IVF FoI No: 567 received 14 July 2016 – treatment policy: 1. According to your current IVF treatment policy: a. How many cycles of IVF do you offer a. How many cycles of IVF do you offer to to eligible patients? 2 eligible patients? b. Do you fund a full cycle of IVF, as defined b. Do you fund a full cycle by NICE, which includes replacement of all of IVF, as defined by NICE, frozen embryos? If not how many frozen embryo transfers do you fund? which includes replacement of
relation to the number of individual biologic drugs in use/on formulary at any one time for use within Rheumatoid Arthritis? -What restrictions (if any) does the CCG’s formulary have in place in relation to the number of individual biologic drugs in use/on formulary at any one time for use within Psoriatic Arthritis? -Finally, could you provide a link/attach to your response the latest versions of your patient pathways for Crohn’s Disease and Psoriatic Arthritis? 2014 TA342 in July 2015 indications applicable locally and confirmed Red ( hospital only) Red prescribing classification. TA352 in September 2015 applicable locally and included. -What restrictions (if any) does the CCG’s formulary have in place in relation to the number of individual biologic drugs in use/on formulary at any one time for use within Rheumatoid Arthritis? Prescribed in line with NICE guidance and as per formulary. No additional restriction. -What restrictions (if any) does the CCG’s formulary have in place in relation to the number of individual biologic drugs in use/on formulary at any one time for use within Psoriatic Arthritis? Prescribed in line with NICE guidance and as per formulary. No additional restriction. -Finally, could you provide a link/attach to your response the latest versions of your patient pathways for Crohn’s Disease and Psoriatic Arthritis? Follow national NICE pathways. FoI No: 567 – received 14 July 2016 1. According to your current IVF treatment policy: a. How many cycles of IVF do you offer to eligible patients? b. Do you fund a full cycle of IVF, as defined by NICE, which includes replacement of all frozen embryos? If not how many frozen embryo transfers do you fund? According to your current IVF treatment policy: a. How many cycles of IVF do you offer to eligible patients? 2 b. Do you fund a full cycle of IVF, as defined by NICE, which includes replacement of
7%20-%20July%202016.docx